Clinical trial
Prevention of Readmissions at Inflammatory Bowel Disease Centres of Excellence
NCT02931799 is registered in ClinicalTrials.gov with Mount Sinai Hospital, Canada as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Readmissions at Inflammatory Bowel Disease Centres of Excellence
- Lead sponsor
- Mount Sinai Hospital, Canada
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 1, 2018
- Completion date
- December 31, 2021
- Enrollment
- 400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.